[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8247 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 8247
To authorize the Secretary of Health and Human Services to award grants
to increase early detection of and intervention for uterine fibroids,
and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 6, 2024
Ms. Brown (for herself, Ms. Clarke of New York, Mrs. Cherfilus-
McCormick, Ms. Lois Frankel of Florida, Mrs. Beatty, Mr. Jackson of
Illinois, Ms. Norton, Ms. Jackson Lee, Ms. Kamlager-Dove, Ms. Kelly of
Illinois, Mrs. Hayes, Mrs. Trahan, Mr. Lieu, Mr. Frost, Ms. Stevens,
Mrs. Watson Coleman, Mrs. Ramirez, Ms. Moore of Wisconsin, Ms.
Strickland, Ms. Jacobs, Mr. Veasey, Ms. Williams of Georgia, Mr.
Grijalva, Ms. Jayapal, Ms. Plaskett, Ms. Pressley, Ms. Sewell, Mr.
Johnson of Georgia, Mr. Casar, Mrs. Foushee, Ms. Blunt Rochester, Mr.
Carson, and Ms. Budzinski) introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To authorize the Secretary of Health and Human Services to award grants
to increase early detection of and intervention for uterine fibroids,
and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Uterine Fibroid Intervention and
Gynecological Health Treatment Act of 2024''.
SEC. 2. RESEARCH ON UTERINE FIBROID EARLY DETECTION AND INTERVENTION.
(a) In General.--The Secretary of Health and Human Services (in
this Act referred to as the ``Secretary'') shall--
(1) conduct or support research on increasing early
detection of, and intervention for, uterine fibroids; and
(2) based on the results of such research and other
relevant information, formulate evidence-based or evidence-
informed strategies to increase early detection in health care
settings.
(b) Timeline.--The Secretary shall finalize the evidence-based or
evidence-informed strategies required by subsection (a)(2) as
expeditiously as possible in order to make such strategies available to
grantees under section 3 to implement such strategies pursuant to
section 3(b)(3).
SEC. 3. GRANTS WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND
INTERVENTION.
(a) In General.--The Secretary of Health and Human Services (in
this Act referred to as the ``Secretary'') may award grants to States
for carrying out programs--
(1) to increase early detection of and intervention for
uterine fibroids; and
(2) to develop and implement public awareness and education
campaigns for the early detection and intervention of uterine
fibroids.
(b) Use of Funds.--A State receiving a grant under this section may
use the grant, with respect to increasing early detection of and
intervention for uterine fibroids, for the following activities:
(1) Screening procedures, including advanced gynecological
imaging (including payment therefor).
(2) Patient navigation services.
(3) Implementation of evidence-based or evidence-informed
strategies proven to increase early detection in health care
settings.
(4) Facilitating access to health care settings.
(c) Priority.--In awarding grants under this section, the Secretary
shall give priority to States proposing to carry out a program in a
geographic areas in which there are socially vulnerable populations
with elevated risk of uterine fibroid development.
SEC. 4. RESEARCH WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND
INTERVENTION.
The Secretary may award grants to conduct research, which may
include clinical trials, related to--
(1) disparities in pain control and management in uterine
fibroid surgical treatment; or
(2) Asherman's Syndrome, intrauterine adhesions, and other
intrauterine conditions as determined appropriate by the
Secretary.
SEC. 5. REPORTS TO CONGRESS.
(a) Reports on Grants.--Not later 2 years after the initial award
of grants under this Act, and every 2 years thereafter, the Secretary
shall submit to the Congress, and make publicly available on the
appropriate website of the Department of Health and Human Services, a
report summarizing the findings and results of programs and activities
funded through grants under this Act.
(b) Report on Research Developments.--Not later than 2 years after
the date of enactment of this Act, and every 2 years thereafter, the
Secretary shall submit to the Congress, and make publicly available on
the appropriate website of the Department of Health and Human Services,
a report outlining research developments and findings related to--
(2) disparities in pain control and management in uterine
fibroid surgical treatment; and
(3) Asherman's Syndrome, intrauterine adhesions, and other
intrauterine conditions as determined appropriate by the
Secretary.
<all>